Risk of recurrence after a first seizure and implications for driving: Further analysis of the multicentre study of early epilepsy and single seizures

BMJ (Online)

Volumn 341, Issue 7785, 2010, Pages 1260-

  Bonnett, L J ^a   Tudur Smith, C ^a   Williamson, P R ^a   Marson, A G ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRIVER; DRIVER LICENCE; DRIVING ABILITY; ELECTROENCEPHALOGRAM; EPILEPSY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; SEIZURE;

ADULT; ANTICONVULSANTS; AUTOMOBILE DRIVING; GREAT BRITAIN; HUMANS; LICENSURE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RECURRENCE; RISK FACTORS; SEIZURES; TIME FACTORS; YOUNG ADULT;

EID: 78650000845     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.c6477     Document Type: Article

References (15)

1. Fisher RS, Parsonage M, Beaussart M, Bladin P, Masland R, Sonnen AEH, et al. Epilepsy and driving - an international perspective. Epilepsia 1994;35:675-84.
2. Second European Working Group on Epilepsy and Driving. Epilepsy and driving in Europe. 2005. http://ec.europa.eu/transport/road-safety/behavior/doc/ epilepsy-and-driving-in-europe-final-report-v2-en.pdf.
3. European Commission for Transport. 2010. http://ec.europa.eu/transport/ index-en.htm.
4. Schmedding E. Epilepsy and driving in Belgium: proposals and justification. Acta Neurologica Belgica 2004;104:68-79.
5. Driver and Vehicle Licensing Agency. At a glance guide to the current medical standards of fitness to drive. Drivers Medical Group, 2010. www.dft.gov.uk/dvla/medical/ataglance.aspx.
6. Krauss GL, Ampaw L, Krumholz A. Individual state driving restrictions for people with epilepsy in the US. Neurology 2001;57:1780-5. (Pubitemid 33096683)
7. Kim LG, Johnson TL, Marson AG, Chadwick DW. Prediction of risk of seizure recurrence after a single seizure and early epilepsy: further results from the MESS trial. Lancet Neurol 2006;5:317-22.
8. Prognosis of epilepsy in newly referred patients: a multicenter prospective study of the effects of monotherapy on the long-term course of epilepsy. Collaborative Group for the Study of Epilepsy. Epilepsia 1992;33:45-51.
9. Marson A, Jacoby A, Johnson A, Kim L, Gamble C, Chadwick D. Immediate versus deferred antiepileptic drug treatment for early epilepsy and single seizures: a randomised controlled trial. Lancet 2005;365:2007-13.
10. Cox DR, Oakes D. Analysis of survival data. Chapman and Hall, 1984.
11. Davis FG, McCarthy BJ, Freels S, Kupelian V, Bondy ML. The conditional probability of survival of patients with primarymalignant brain tumors - surveillance, epidemiology, and end results (SEER) data. Cancer 1999;85:485-91.
12. Lin CL, Lieu AS, Lee KS, Yang YH C, Kuo TH, Hung MH, et al. The conditional probabilities of survival in patients with anaplastic astrocytoma or glioblastoma multiforme. Surg Neurol 2003;60:402-6.
13. Akaike H. A new look at the statistical model identification. IEEE Trans Automat Contr 1974;19:716-23.
14. Collett D.Modelling survival data inmedical research. Chapman and Hall, 2003.
15. Hart YM, Sander JW, Johnson AL, Shorvon SD. National General Practice Study of Epilepsy: recurrence after a first seizure. Lancet 1990;336:1271-4.